New and Media

Media Release
March 18, 2021
Nationwide Children’s Hospital Affiliate Andelyn Biosciences Receives Significant Investment and Enters Into Strategic Partnership with Pall Corporation and Cytiva
Blog
February 15, 2021
“What’s in a name?” the saying goes. In this case, much more than meets the eye. Andelyn Biosciences is much...
Media Release
November 25, 2020
COLUMBUS, Ohio – Andelyn Biosciences, an affiliate company of Nationwide Children’s Hospital that manufactures gene therapy products for the biotechnology and pharmaceutical...
Blog
November 15, 2020
Viral vectors are an essential part of gene therapy treatments. They are essential for delivering corrected genetic information to faulty...
Blog
September 15, 2020
Gene therapy has revolutionized medicine since the early 1990s and is one of the most promising fields in medicine. In...
Blog
July 20, 2020
Current Good Manufacturing Processes (cGMP) are outlined by the FDA, which defines them as the “minimum requirements for the methods,...
Blog
April 15, 2020
Gene therapy is the process of replacing damaged or unhealthy genetic material with new material for treating various diseases and...
Research
May 28, 2019
Researchers identify a key regulatory protein implicated in Galgt2 overexpression and begin to elucidate its protective mechanism against muscular dystrophy.
Research
April 19, 2019
Researchers recently published the long-term outcomes of patients who received the investigational drug AVXS-101 – an adeno-associated virus serotype 9 mediated gene replacement therapy.
Research
November 16, 2018
The model aims to provide the basis for many future studies to bring therapeutic options to patients with FSHD.
Research
July 24, 2018
Tests of NT-3 gene therapy on mouse models suggest potential to treat a host of muscle-wasting conditions.